These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 27102582)

  • 1. The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases.
    Olsen MA; Young-Xu Y; Stwalley D; Kelly CP; Gerding DN; Saeed MJ; Mahé C; Dubberke ER
    BMC Infect Dis; 2016 Apr; 16():177. PubMed ID: 27102582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of Clostridium difficile-associated disease among patients residing in nursing homes: a population-based cohort study.
    Yu H; Baser O; Wang L
    BMC Geriatr; 2016 Nov; 16(1):193. PubMed ID: 27884118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care resource utilization and costs of recurrent
    Nelson WW; Scott TA; Boules M; Teigland C; Parente A; Unni S; Feuerstadt P
    J Manag Care Spec Pharm; 2021 Jul; 27(7):828-838. PubMed ID: 33703939
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
    Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
    Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridioides (Clostridium) difficile infection in Japanese hospitals 2008-2017: A real-world nationwide analysis of treatment pattern, incidence and testing density.
    Kimura T; Stanhope S; Sugitani T
    J Infect Chemother; 2020 May; 26(5):438-443. PubMed ID: 32081648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the incidence of
    Olsen MA; Stwalley D; Tipping AD; Keller MR; Yu H; Dubberke ER
    Infect Control Hosp Epidemiol; 2023 Jul; 44(7):1076-1084. PubMed ID: 36082779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The burden of Clostridium difficile in surgical patients in the United States.
    Zerey M; Paton BL; Lincourt AE; Gersin KS; Kercher KW; Heniford BT
    Surg Infect (Larchmt); 2007 Dec; 8(6):557-66. PubMed ID: 18171114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality and Costs in Clostridium difficile Infection Among the Elderly in the United States.
    Shorr AF; Zilberberg MD; Wang L; Baser O; Yu H
    Infect Control Hosp Epidemiol; 2016 Nov; 37(11):1331-1336. PubMed ID: 27572289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trend, Risk Factors, and Costs of Clostridium difficile Infections in Vascular Surgery.
    Egorova NN; Siracuse JJ; McKinsey JF; Nowygrod R
    Ann Vasc Surg; 2015; 29(4):792-800. PubMed ID: 25595110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile infection in the "oldest" old: clinical outcomes in patients aged 80 and older.
    Cober ED; Malani PN
    J Am Geriatr Soc; 2009 Apr; 57(4):659-62. PubMed ID: 19392957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comprehensive Study of Costs Associated With Recurrent Clostridium difficile Infection.
    Rodrigues R; Barber GE; Ananthakrishnan AN
    Infect Control Hosp Epidemiol; 2017 Feb; 38(2):196-202. PubMed ID: 27817758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile infection in patients hospitalized with type 2 diabetes mellitus and its impact on morbidity, mortality, and the costs of inpatient care.
    Olanipekun TO; Salemi JL; Mejia de Grubb MC; Gonzalez SJ; Zoorob RJ
    Diabetes Res Clin Pract; 2016 Jun; 116():68-79. PubMed ID: 27321318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset.
    Kimura T; Snijder R; Sugitani T
    J Infect Chemother; 2019 Aug; 25(8):615-620. PubMed ID: 30987950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of International Classification of Diseases, Ninth Revision, Clinical Modification codes and medication use data to identify nosocomial Clostridium difficile infection.
    Schmiedeskamp M; Harpe S; Polk R; Oinonen M; Pakyz A
    Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1070-6. PubMed ID: 19803724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of Clostridium difficile infection (CDI) in a community hospital.
    Daniel A; Rapose A
    J Infect Public Health; 2015; 8(2):155-60. PubMed ID: 25301221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality, Health Care Use, and Costs of Clostridioides difficile Infections in Older Adults.
    Feuerstadt P; Nelson WW; Drozd EM; Dreyfus J; Dahdal DN; Wong AC; Mohammadi I; Teigland C; Amin A
    J Am Med Dir Assoc; 2022 Oct; 23(10):1721-1728.e19. PubMed ID: 35288083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals.
    Le Monnier A; Duburcq A; Zahar JR; Corvec S; Guillard T; Cattoir V; Woerther PL; Fihman V; Lalande V; Jacquier H; Mizrahi A; Farfour E; Morand P; Marcadé G; Coulomb S; Torreton E; Fagnani F; Barbut F;
    J Hosp Infect; 2015 Oct; 91(2):117-22. PubMed ID: 26253518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital Clostridium difficile Infection Rates and Prediction of Length of Stay in Patients Without C. difficile Infection.
    Miller AC; Polgreen LA; Cavanaugh JE; Polgreen PM
    Infect Control Hosp Epidemiol; 2016 Apr; 37(4):404-10. PubMed ID: 26858126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inpatient Expenditures Attributable to Hospital-Onset Clostridium difficile Infection: A Nationwide Case-Control Study in Japan.
    Fukuda H; Yano T; Shimono N
    Pharmacoeconomics; 2018 Nov; 36(11):1367-1376. PubMed ID: 30022364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.